Spravato (esketamine nasal spray) is covered by most major insurance plans, including commercial insurance, Medicare, and Medicaid. However, coverage almost always comes with restrictions. You’ll likely need prior authorization, and your insurer may require documentation that other treatments have failed before approving it. The path to getting coverage can be straightforward or frustrating depending on your specific plan and diagnosis.
What Most Insurance Plans Require
Spravato is FDA-approved for two specific uses: treatment-resistant depression in adults (either alone or alongside an oral antidepressant) and depressive symptoms in adults with major depressive disorder who have acute suicidal thoughts or behavior. Insurance companies typically limit coverage to these two indications. If your doctor is prescribing it for a different reason, your claim will likely be denied.
For treatment-resistant depression, most insurers want evidence that you’ve tried and failed at least two oral antidepressants at adequate doses before they’ll approve Spravato. This is consistent with the clinical definition of treatment-resistant depression itself. Your provider will need to submit documentation of your medication history as part of the prior authorization process.
Even when you meet the clinical criteria, your plan may impose additional restrictions. Some insurers use a behavioral health organization to manage mental health benefits separately from general medical coverage. If your plan works this way, the behavioral health organization is the one making the coverage decision, and your provider may need to contact them directly to understand reimbursement options.
How Medicare Covers Spravato
Medicare generally covers Spravato under Part B rather than Part D, because it’s administered in a healthcare setting under direct medical supervision rather than taken at home. Medicare covers drugs that are given as part of a physician’s service and aren’t self-administered by the patient. Spravato fits this category perfectly since the FDA requires it to be given in a certified clinic.
Under Medicare, the treatment schedule follows the FDA label: twice per week during the first month, once weekly during the second month, then every one to two weeks after that. Medicare may flag claims for medical review if the frequency exceeds these parameters, specifically more than 8 sessions in the first month, more than 4 in the second month, or more than 4 in any subsequent month.
Medicaid Coverage Varies by State
Medicaid programs cover Spravato, but the specifics depend on your state. North Carolina Medicaid, for example, has covered it since March 2019 through its physician-administered drug program. Other states have their own billing guidelines and prior authorization requirements. If you’re on Medicaid, your provider’s office will need to verify your state’s specific policies before starting treatment.
Why the Treatment Setting Affects Your Bill
Spravato can’t be picked up at a pharmacy and used at home. The FDA’s safety program requires every dose to be taken in a certified healthcare setting, under direct observation by a healthcare provider. After each dose, you must be monitored for at least two hours for sedation, dissociation, and changes in vital signs. Only then can you leave, and you can’t drive for the rest of the day.
This means your insurance claim has two components: the drug itself and the observation period. Some plans cover the drug under the pharmacy benefit and the monitoring under the medical benefit, while others route everything through one or the other. This split can create confusion. Your provider should check with your plan to understand which pathway is preferred, because billing through the wrong channel can result in a denial that has nothing to do with medical necessity.
What to Do If You’re Denied
Denials are common with Spravato, and they don’t necessarily mean your plan won’t cover it. The first step is a medical exception request, where your doctor submits additional clinical information explaining why Spravato is medically necessary for you specifically. If the exception is denied on clinical grounds, you can file a formal appeal with your health plan. Many patients who are initially denied end up getting coverage through one of these routes.
Your provider’s office typically handles this paperwork, but it helps to stay involved. Ask for copies of denial letters so you understand the stated reason. Sometimes the issue is as simple as missing documentation or incorrect billing codes rather than a genuine coverage exclusion.
Help With Out-of-Pocket Costs
Without insurance, Spravato is expensive. The drug cost alone runs into hundreds of dollars per session, and you’re looking at up to eight sessions in the first month. Add the required monitoring fees, and the total climbs quickly.
Johnson & Johnson, the manufacturer, offers a patient assistance program that can provide the medication at no cost for up to one year. This is available if you’re uninsured, but also if you have commercial, employer-sponsored, or government coverage that doesn’t fully cover the drug. Eligibility depends on income requirements. Even if you have insurance with high copays or coinsurance, this program may help bridge the gap.
If you have commercial insurance, separate copay assistance programs can reduce your per-session cost. These programs typically don’t apply to government insurance like Medicare or Medicaid, but the patient assistance program mentioned above can fill that role for government plan members who qualify.